Background {#Sec1}
==========

Bronchiolitis obliterans (BO) is an uncommon and severe sequela of chronic obstructive lung disease in children that results from certain insult to the lower respiratory tract. It is featured by tachypnoea, increased anteroposterior chest diameter, crackles, wheezing, and hypoxaemia for at least 30 days after the initial insult. Luminal obstruction with inflammation, granulation tissue, fibrosis, obliteration of the small airways and bronchiectasis are the pathological characteristics (Li et al. [@CR16]; Champs et al. [@CR3]; Xie et al. [@CR23]; Bosa et al. [@CR2]; Mosquera et al. [@CR18]). Due to its poor prognosis and shortage of effective remedy, identification of predictive factors for BO became one of hottest topic in this field. However, few prognostic factors achieved worldwide acknowledgment (Murtagh et al. [@CR19]; Colom and Teper [@CR4]; Yalcin et al. [@CR24]; Khalifah et al. [@CR14]). The latent causes might be the heterogenicity of this disease.

BO was a heterogeneous syndrome due to multiple causes. The reported causes were indicated as acute rejection (El-Gamel et al. [@CR6]), lymphocytic bronchitis (Husain et al. [@CR12]), cytomegalovirus pneumonitis (Heng et al. [@CR11]), adenoviral infection (Murtagh et al. [@CR19]), single lung transplant (Hadjiliadis et al. [@CR9]), anti-human leukocyte antigen antibody development (Palmer et al. [@CR21]), and et al. (Champs et al. [@CR3]). The predictors for BO in various backgrounds shall be divergent widely due to different latent mechanisms. Thus prognostic analysis of BO shall be based on a single cause. Adenoviral infection was identified as the major cause for BO in children (Champs et al. [@CR3]; Murtagh et al. [@CR19]; Khalifah et al. [@CR14]). Thus, it is imperative to investigate the predictors for BO following respiratory adenoviral infection in children.

In our Women and Children's Medical Center, a 1400 bed tertiary children's hospital located in Southern China with a service population of around 20 million people, we routinely test adenovirus in nasopharyngeal swabs by RT-PCR assay or using serum IgM for in-hospital children with acute respiratory infection (ARI) since Jan 2011. In the present study, we retrospectively collected the children with respiratory adenoviral infection and identified the predictive factors of BO.

Methods {#Sec2}
=======

Patients {#Sec3}
--------

In the period between Jan 2011 and December 2014, the consecutive in-hospital ARI children with positive result for adenovirus in nasopharyngeal swabs by RT-PCR assay or serum IgM/IgG were enrolled into the present study. Diagnosis and classification of ARI followed standard WHO algorithm for ARI. Briefly, children with cough, difficult breathing, or both were diagnosed ARI and screened for fast breathing. Children were classified as Table [1](#Tab1){ref-type="table"} (WHO [@CR20]; Hazir et al. [@CR10]). Patients with one of following conditions were excluded from this study: patients presented congenital heart disease, congenital pulmonary dysplasia, immunodeficiency disease, malignances, severe organ dysfunction, had recently been pyrexial for 7 days before admission (temperature under the axillary is at or over 37.2 °C, had exhibited clinical evidence of active infection in other organs, had received corticosteroids within 1 week before admission for any reason and those with substantial missing data. The study was approved by the ethical committee of the Guangzhou Medical University, as well as the Guangzhou Women and Children's Medical Center Hospital; written informed consent was obtained from the patients' parents.Table 1World Health Organization classification of acute respiratory illness in children presenting with cough and/or difficult breathingClassificationCriteriaNo pneumonia (cough and cold)Respiratory rate (breaths/minute)\<50 (infants 2--11 months)\<40 (children 12--59 months)No lower chest indrawingNonsevere pneumoniaRespiratory rate (breaths/minute)\>50 (infants 2--11 months)\<40 (children 12--59 months)No lower chest indrawingSevere pneumoniaLower chest indrawing with or without rapid breathingVery severe diseaseUnable to drink, convulsions, abnormally sleepy or difficult waking, stridor in calm child or clinically severe malnutrition

Diagnosis of adenovirus infection {#Sec4}
---------------------------------

PCRs with DNA targets utilized 10 μl purified nucleic acid from Qiagen Quantitect Probe PCR kit (Qiagen, Crawley, UK). Thermal cycling conditions were as described previously, except for removal of the 50 °C hold for reverse transcription, and the enzyme activation hold at 95 °C was extended to fifteen minutes for the Qiagen Quantitect Probe PCR kit. All assays were performed in a Lightcycler 480 real-time PCR machine (Roche Diagnostics, Burgess Hill, UK). The Primers were forward "GCC ACG GTG GGG TTT CTA AAC TT", reverse "GCC CCA GTG GTC TTA CAT GCA CAT C" and the sequence of the probe was "TGC ACC AGA CCC GGG CTC AGG TAC TCC GA" (Bezerra et al. [@CR1]). Serum adenovirus IgM/IgG were tested using diagnostic ELISA kit (IMMUNOLAB GmbH, Kassel).

Identification of BO {#Sec5}
--------------------

High resolution computerized tomography (HRCT) was utilized as the diagnostic technique for BO. It was conducted when children presented tachypnoea, increased anteroposterior chest diameter, crackles, wheezing or hypoxaemia for at least 30 days after the initial of acute respiratory infection. The chest HRCT was performed during quiet breathing and evaluated by 2 blinded radiologists. BO was defined on the presence of bronchiectasis and/or a mosaic pattern. Mosaic pattern was defined as segmental orlobular areas of hypoattenuation that are associated with narrowing of the caliber of the pulmonary vessels.

Data collection and follow up {#Sec6}
-----------------------------

Data as follows were included: gender, age, history of breast-feeding, premature birth, number of siblings, extention of infection (no pneumonia, pneumonia), and blood tests before treatment such as blood neutrophil count, blood lymphocyte count, alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatinine kinase (CK), CK-MB, lactate dehydrogenase (LDH), and C-reactive protein (CRP), as well as parameters identified after admission including hypoxemia, mycoplasma co-infection, bacterial co-infection, sepsis, usage of γ-globulin intravenously, use of antibiotics, use of glucocorticoids, mechanical ventilation, length of fever and length of hospital stay.

We conducted a routine follow-up from admission to 1 month after delivery and recorded the following in detail: symptoms, concomitant medications and adverse reactions. All the children were followed up regularly, either at the clinic or by telephone.

Statistical analysis {#Sec7}
--------------------

The Kolmogorov--Smirnov test was used to evaluate the normality of distribution. Data were reported as median and range when distribution was not normal. Statistical differences in clinical characteristics between the 2 groups were compared using the *t* test, the Mann--Whitney test, and Fisher's exact test. Group comparison tests were performed using the Wilcoxon rank-sum test. Multivariate analysis using a Logistic proportional hazards model was used to test for independent significance by backward elimination of insignificant baseline characteristics and explanatory variables. For all tests, a *p* value \< 0.05 was considered statistically significant, and all *p* values quoted are 2-sided. Statistical analyses were performed using SPSS v. 20.0 (SPSS Inc., Chicago, IL, USA).

Results {#Sec8}
=======

Patient characteristics of children with or without BO following respiratory adenoviral infection {#Sec9}
-------------------------------------------------------------------------------------------------

A total of 544 children (398 boys and 146 girls) met the eligibility criteria and were available for analysis. Among the 544 children, 456 children were diagnosed through PCR and 56 were by serum IgM with the rest 32 diagnosed by both methods. In the serology only group, seroconversion were confirmed in 47/56 (83.9 %) patients. The children had a median age of 23 months (range 1--144 months). 14 (2.57 %) patients developed BO who were all diagnosed pneumonia at admission. Compared with children without BO, BO children presented higher LDH (523.5 vs. 348 IU/ml, *p* = 0.033), lower blood lymphocyte count (2.23 × 10^9^/L vs. 3.24 × 10^9^/L, *p* = 0.025) and higher incidence of hypoxemia (78.6 vs. 20.8 %, *p* = 0.000). They presented relatively persistent fever (15.5 vs. 7 days, *p* = 0.000) and needed longer treatment in hospital (19.5 vs. 7 days, *p* = 0.000). Concerning treatment, they were given more intravenous γ-globulin (85.7 vs. 36.8 %, *p* = 0.000), glucocorticoids (78.6 vs. 24.3 %, *p* = 0.000) and mechanical ventilation (35.7 vs. 5.5 %, *p* = 0.001) (Table [2](#Tab2){ref-type="table"}).Table 2Characteristics of children with or without bronchiolitis obliterans after respiratory adenoviral infectionCharacteristicsNon-BO (n = 530)BO (n = 14)*p*Gender0.127 Male385 (72.6 %)13 (92.9 %) Female145 (27.4 %)1 (7.1 %)Age (months)23.5 (1--144)15.5 (6--72)0.339History of breast-feeding305 (57.5 %)9 (64.3 %)0.818Premature birth34(6.4 %)1 (7.1 %)0.610Number of siblings0 (0--3)1 (0--2)0.096Diagnosis0.014 No pneumonia150 (28.3 %)0 (0.0 %) Pneumonia380 (71.7 %)14 (100.0 %) Hypoxemia110 (20.8 %)11 (78.6 %)0.000CRP14.92 (0.00--264.74)26.25 (0.51--116.20)0.155Blood neutrophil count (×10^9^/l)5.49 (0.54--32.8)4.46 (2.19--14.44)0.767Blood lymphocyte count (×10^9^/l)3.24 (0.36--35.29)2.23 (0.83--6.77)0.025ALT (IU/ml)18 (3--372)16 (7--112)0.405AST (IU/ml)41 (15--1400)40.5 (29--391)0.495CK (IU/ml)88.5 (11--5413)91 (17--1038)0.941CK--MB (IU/ml)25 (1--436)24 (13--169)0.959LDH (IU/ml)348 (14--10983)523.5 (254--1945)0.033Mycoplasma co-infection143 (27.0 %)4 (28.6)0.999Bacterial co-infection46 (8.7 %)0 (0.0 %)0.621Sepsis9 (1.7 %)0 (0.0 %)0.999Use of γ-globulin intravenously195 (36.8 %)12 (85.7 %)0.000Use of antibiotics509 (96.0 %)14 (100.0 %)0.999Use of glucocorticoids129 (24.3 %)11 (78.6 %)0.000Mechanical ventilation29 (5.5 %)5 (35.7 %)0.001Length of fever (days)7 (0--62)15.5 (6--30)0.000Length of hospital stay (days)7 (2--74)19.5 (8--55)0.000*BO* bronchiolitis obliterans, *ALT* alanine aminotransferase, *AST* aspartate aminotransferase, *CK* creatinine kinase, *LDH* lactate dehydrogenase, *CRP* C-reactive protein

Predictors of BO following respiratory adenoviral infection in children {#Sec10}
-----------------------------------------------------------------------

Univariate analysis by Logistic regression revealed that length of hospital stay (*p* = 0.000, HR 1.086, 95 % CI 1.046--1.127), length of fever (*p* = 0.003, HR 1.062, 95 % CI 1.020--1.106), use of glucocorticoids (*p* = 0.000, HR 11.398, 95 % CI 3.131--41.486), mechanical ventilation (*p* = 0.000, HR 9.598, 95 % CI 3.022--30.480), hypoxemia (*p* = 0.000, HR 14.000, 95 % CI 3.839--51.050) and use of intravenous γ-globulin (*p* = 0.002, HR 10.308, 95 % CI 2.283--46.535) were indicated as prognostic factors. Then, multiple analysis by Logistic regression using above parameters determined that hypoxemia was the only independent predictor for BO (*p* = 0.030, HR 5.046, 95 % CI 1.170--21.765) (Table [3](#Tab3){ref-type="table"}). Then, patients with or without hypoxemia were compared concerning the incidence of BO, which indicated that patients with hypoxemia kept significantly higher incidence of BO than those without hypoxemia (Fig. [1](#Fig1){ref-type="fig"}).Table 3Logistic analysis of predictive parametersFactorsUnivariate analysisMultivariate analysis*p*HR (95 % CI)*p*HR (95 % CI)Length of hospital stay0.0001.086 (1.046--1.127)0.0561.044 (0.999--1.090)Length of fever0.0031.062 (1.020--1.106)0.9971.000 (0.942--1.062)Use of glucocorticoids0.00011.398 (3.131--41.486)0.0564.036 (0.964--16.907)Mechanical ventilation0.0009.598 (3.022--30.480)0.6121.438 (0.354--5.849)Hypoxemia0.00014.000 (3.839--51.050)0.0305.046 (1.170--21.765)Use of γ-globulin intravenously0.00210.308 (2.283--46.535)0.4741.935 (0.317--11.806)*95* *% CI* 95 % confidence intervalFig. 1Incidence of BO in adenovirus infected children with or without hypoxemia. *BO* bronchiolitis obliterans

Discussion {#Sec11}
==========

BO is a severe chronic sequelain children following respiratory adenoviral infection (Champs et al. [@CR3]; Murtagh et al. [@CR19]). Due to its low incidence, the predictors of BO were still unclear. Respiratory viral infection was confirmed to be a distinct risk for BO (Khalifah et al. [@CR14]). Among the entire suspected virus, adenovirus was confirmed to be the major causes (Murtagh et al. [@CR19]). Previous studies found that mechanical ventilation, \>30 days of hospitalization, multifocal pneumonia and hypercapnia were the predictors of BO in children with acute bronchitis (Murtagh et al. [@CR19]; Colom and Teper [@CR4]; Yalcin et al. [@CR24]; Khalifah et al. [@CR14]). Some studies failed to identify the predictors due to limited sample sizes (Yalcin et al. [@CR24]). Above all, few prognostic factors achieved worldwide acknowledgment, which might due to limited sample sizes and the heterogenicity of this disease.

In the present study, we found that hypoxemia was the independent predictor of BO in adenovirus infected children, which was a novel finding. It usually preceded the previous reported risk factors such as hypercapnia and mechanical ventilation (Jouett et al. [@CR13]; Wilson and Matthay [@CR22]), which made it more sensitive than other predictors. The causes and mechanism of development of BO was still unclear (Kim et al. [@CR15]; Gedik et al. [@CR7]; Costa et al. [@CR5]; Mallol et al. [@CR17]). In order to achieve reliable results, prognostic analysis of BO shall be based on simple disease background. Since adenoviral infection was identified as the major cause of BO in children (Murtagh et al. [@CR19]), it is optimal to investigate the predictors for BO following respiratory adenoviral infection in children. Due to the low incidence of BO, multiple center based studies shall be the optimal choice for better understanding of this sequela.

In the present study, pulmonary function measurements were not conducted due the ages of BO children. Most of them are younger than 5 years, which made the pulmonary function measurements unreliable due to their incompatibility. Meanwhile, pathological diagnosis was not achieved due to the risk of biopsy in symptomatic young children and reluctance of their parents. However, the diagnosis of BO in most of the studies was not based on pathological diagnosis (Li et al. [@CR16]; Gedik et al. [@CR7]; Giubergia et al. [@CR8]). And diagnosis based on CT and clinical features was acceptable to most of the researchers. We did not test co-infection of other virus and specific types of adenovirus, due to the low incidence of BO and sub-analysis needed multi-center based studies with larger sample sizes.

Conclusions {#Sec12}
===========

In summary, the present study identified hypoxemia as the independent predictive factor of BO in adenoviral infected children, which was a novel and sensitive predictor.
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